Investigating a key signaling molecule in liver cancer
Mixed Lineage Kinase 3 and cytokine signaling axis in hepatocellular carcinoma
This study is looking at how a protein called MLK3 affects liver cancer growth and survival, with the hope of finding new ways to treat patients with this type of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jesse Brown VA Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10948913 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of Mixed-Lineage Kinase 3 (MLK3) in the progression of hepatocellular carcinoma (HCC), a common and deadly form of liver cancer. By using a model that mimics liver cancer development, researchers are examining how the absence of MLK3 affects tumor growth and cell survival. They are also exploring how MLK3 interacts with cytokines, which are signaling molecules that can influence cancer progression. The goal is to identify new therapeutic strategies that could target this signaling pathway to improve treatment options for patients with HCC.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hepatocellular carcinoma or those at high risk for developing liver cancer.
Not a fit: Patients with other types of cancer or those without liver disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically target the mechanisms driving liver cancer, potentially improving survival rates for patients.
How similar studies have performed: Previous research has shown promising results in targeting similar signaling pathways in cancer treatment, indicating potential for success in this approach.
Where this research is happening
Chicago, United States
- Jesse Brown VA Medical Center — Chicago, United States (Active)
Researchers
- Principal investigator: Rana, Basabi — Jesse Brown VA Medical Center
- Study coordinator: Rana, Basabi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.